Eric Schmidt

Work Performance Price Targets & Ratings Chart

Analyst Eric Schmidt, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 53.61% that have a potential upside of 23.43% achieved within 691 days.

Eric Schmidt’s has documented 62 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RNA, Avidity Biosciences at 27-Jun-2025.

Wall Street Analyst Eric Schmidt

Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.

Average potential price target upside

of $71.89 (55.55%) on AMGN (AMGEN).
of $51.94 (41.52%) on ALXN (ALEXION PHARMACEUTICALS).
of $49.92 (16.55%) on BIIB (BIOGEN).

BIIB Biogen CELG Celgene INCY yte AMGN Amgen ALXN Alexion Pharmaceuticals BLUE Bluebird bio AGIO Agios Pharm CRSP Crispr Therapeutics AG IMCR Immunocore Holdings Ltd IMTX Immatics NV RNA Avidity Biosciences TNGX Tango Therapeutics ALMS Alumis Common Stock ADCT ADC Therapeutics SA AKCA Akcea Therapeutics CDTX Cidara Therapeutics PRTA Prothena plc RARE Ultragenyx SMMT Summit Therapeutics PLC

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score